Mark C. Wenlock
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
-
- Computational Drug Discovery Methods
Papers in
-
- Computational Drug Discovery Methods 13
- Spectroscopy 11
- Analytical Chemistry and Chromatography 11
- Co-authors
- Patrick Barton (10 shared papers)Rupert P. Austin (7 shared papers)Paul D. Leeson (3 shared papers)Andrew Davis (3 shared papers)Scott L. Cockroft (1 shared paper)Robert J. Riley (1 shared paper)Stephen A. St-Gallay (2 shared papers)Lars Carlsson (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)MedChemComm (5 papers)Journal of Computer-Aided Molecular Design (2 papers)Pharmaceutical Research (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomSwedenDenmark
In The Last Decade
Mark C. Wenlock
21 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 368
- Computational Theory and Mathematics 541
- Spectroscopy 211
- Pharmaceutical Science 75
- Oncology 243
Countries citing papers authored by Mark C. Wenlock
This map shows the geographic impact of Mark C. Wenlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Wenlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Wenlock more than expected).
Fields of papers citing papers by Mark C. Wenlock
This network shows the impact of papers produced by Mark C. Wenlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Wenlock. The network helps show where Mark C. Wenlock may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark C. Wenlock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 462 | |
| 2 | 2002 | 347 | |
| 3 | 2010 | 73 | |
| 4 | 2011 | 60 | |
| 5 | 2011 | 52 | |
| 6 | 2014 | 50 | |
| 7 | 2013 | 48 | |
| 8 | 2011 | 32 | |
| 9 | 2021 | 28 | |
| 10 | 2005 | 28 | |
| 11 | 2007 | 21 | |
| 12 | 2011 | 14 | |
| 13 | 2011 | 14 | |
| 14 | 2016 | 13 | |
| 15 | 2011 | 12 | |
| 16 | 2011 | 9 | |
| 17 | 2011 | 8 | |
| 18 | 2021 | 6 | |
| 19 | 2017 | 4 | |
| 20 | 2015 | 2 |
About Mark C. Wenlock
Mark C. Wenlock is a scholar working on Computational Theory and Mathematics, Spectroscopy, Pharmacology, Analytical Chemistry and Oncology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (13 papers), Analytical Chemistry and Chromatography (11 papers), Analytical Methods in Pharmaceuticals (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Protein Interaction Studies and Fluorescence Analysis (2 papers), S100 Proteins and Annexins (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Pharmacology (368 citations), Computational Theory and Mathematics (541 citations), Spectroscopy (211 citations), Pharmaceutical Science (75 citations) and Oncology (243 citations). Mark C. Wenlock has collaborated with scholars based in United Kingdom, Sweden and Denmark. Frequent co-authors include Patrick Barton, Rupert P. Austin, Paul D. Leeson, Andrew Davis, Scott L. Cockroft, Robert J. Riley, Stephen A. St-Gallay, Lars Carlsson, Tim J. Luker and Laurent David. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, MedChemComm, Journal of Computer-Aided Molecular Design, Pharmaceutical Research and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.